Did you know that modern systems like the TrueBeam STx can deliver radiation with sub-millimetre accuracy and significantly shorten treatment time for patients? This remarkable leap in cancer treatment technology represents the future of precision care. At the forefront of this revolution in India is Dr Mathangi J—Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore—who combines the art of compassionate care with the science of cutting-edge radiation therapy.
In today’s medical landscape, precision is everything. The goal is simple yet profound: eradicate the tumour while protecting healthy tissue. That’s where precision oncology becomes invaluable. At Gleneagles Cancer Institute, under the leadership of Dr Mathangi, every radiation plan is customised, leveraging TrueBeam STx radiotherapy and other advanced radiotherapy techniques to deliver results with accuracy and safety. For conditions such as head and neck cancer or brain tumors, this technology-driven precision can directly influence patient recovery and quality of life.
TrueBeam STx radiotherapy is an advanced system designed to deliver high-energy beams directly to cancerous tissues with incredible precision. It integrates imaging, beam-shaping, and motion management to target tumours while minimising exposure to nearby healthy organs. This system allows clinicians like Dr Mathangi to treat cancers in complex and sensitive areas—such as the brain, lung, spine, and liver—with confidence and accuracy.
At its core, the TrueBeam STx platform exemplifies technological excellence by enabling faster treatment sessions, real-time imaging, and seamless adaptability to patient movement. These advancements translate to safer, more efficient, and more comfortable treatment experiences for patients.
Stereotactic radiosurgery (SRS) is a specialised form of radiation treatment that delivers high-dose radiation in one or a few sessions to precisely defined areas. Under Dr Mathangi’s care, SRS and other advanced radiotherapy techniques such as SBRT (stereotactic body radiotherapy), IGRT (image-guided radiotherapy), and DIBH (deep inspiration breath-hold) radiotherapy are used to treat tumours that require ultra-fine targeting.
| Technique | Ideal application | Benefit |
|---|---|---|
| Stereotactic radiosurgery (SRS) | Brain tumors, small lesions near critical structures | High-dose precision with minimal healthy tissue impact |
| SBRT | Lung, liver, and spine tumours | Fewer sessions and precise targeting |
| IGRT with motion control | Tumours that move with breathing or organ motion | Real-time imaging ensures exact dose placement |
Combining TrueBeam STx radiotherapy with these advanced methods ensures that patients receive radiation treatment that’s both powerful and precisely delivered.
Dr Mathangi’s expertise extends across numerous cancer types that demand accuracy and delicate planning. These include:
For instance, in head and neck cancer, preserving vital functions like swallowing and speech is critical. Advanced technology allows precise tumour targeting without compromising the surrounding healthy structures—an essential outcome that conventional radiation often struggles to achieve.
Targeted therapy and precision oncology revolutionise how radiation is delivered by personalising every step to the patient’s biology and tumour behaviour. At Gleneagles Cancer Institute, Dr Mathangi integrates genomic data, advanced imaging, and adaptive planning to ensure that radiation doses are directed exactly where they are needed most. This personalised approach reduces complications, enhances tumour control, and aligns perfectly with global oncology best practices.
Patients who embrace precision oncology benefit from more efficient treatments, shorter recovery periods, and improved long-term outcomes. By choosing a leading expert like Dr Mathangi, you are choosing assurance, expertise, and results backed by experience and technology.
Dr Mathangi’s patient-centric process is designed for clarity, comfort, and confidence:
This process ensures each patient receives not only treatment but also guidance, care, and reassurance throughout their journey.
Clinical studies worldwide affirm that TrueBeam STx radiotherapy achieves superior accuracy and reduced treatment times compared to conventional methods. The system’s integration of imaging and beam modulation has been shown to decrease toxicity while increasing control rates for complex cancers such as brain tumors and head and neck cancer. At Gleneagles Cancer Institute, these global standards meet local expertise through Dr Mathangi’s experienced hands.
Dr Mathangi J has more than 20 years of experience in radiation oncology and has successfully treated over 12,000 patients. She has undergone international training in Germany and Denmark, specialising in stereotactic radiosurgery, IGRT, and intraoperative radiotherapy. Her department houses the Asia-Pacific’s first TrueBeam STx installation, setting a new benchmark for precision treatment in India.
Her leadership at Gleneagles Cancer Institute ensures that patients receive not only access to world-class technology but also a personalised care plan guided by compassion and evidence-based medicine.
Access to cutting-edge cancer care is just one step away. To book an appointment with Dr Mathangi, simply submit your contact information through https://drmathangi.com/contact/. Her team will schedule your consultation and guide you through the next steps of your personalised treatment plan.
The integration of TrueBeam STx radiotherapy and advanced radiotherapy techniques marks a new era in precision oncology. For patients with cancers like head and neck cancer or brain tumors, the difference between good and exceptional care lies in accuracy and experience. Under the guidance of Dr Mathangi J, Gleneagles Cancer Institute offers both—science-led precision and human-centred care. Choose expertise, choose innovation, choose better outcomes.
Dr Mathangi J is the Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. With qualifications including MBBS, DMRT, and DNB, she brings over two decades of clinical excellence to her patients. Internationally trained in Germany and Denmark, she is renowned for her expertise in stereotactic radiosurgery, TrueBeam STx radiotherapy, and targeted therapy. She leads the Advanced Fellowship Programme in Radiotherapy affiliated with RGUHS and has successfully treated more than 12,000 patients across India.
